Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Popa

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Molecular Sciences|December 9, 2023
The Role of KRAS Mutation in Colorectal Cancer-Associated ThrombosisRadu Andrei Emilescu, Mariana Jinga, Horia Teodor Cotan, et al.
Experimental and Therapeutic Medicine|May 27, 2022
Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort studyCornelia Nitipir, Andreea Ioana Parosanu, Mihaela Olaru, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature ReviewIoana-Miruna Stanciu, Cristina Florina Pirlog, Andrei-Wilhelm Anghel, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?Cristina-Florina Pîrlog, Raluca Costache, Andreea Ioana Paroșanu, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell CarcinomaAndreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, et al.
Oncology Letters|January 19, 2018
Update on radionuclide therapy in oncologyCornelia Nitipir, Dana Niculae, Cristina Orlov, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Molecular Sciences|December 9, 2023
The Role of KRAS Mutation in Colorectal Cancer-Associated ThrombosisRadu Andrei Emilescu, Mariana Jinga, Horia Teodor Cotan, et al.
Experimental and Therapeutic Medicine|May 27, 2022
Infection and reinfection with SARS-CoV-2 in cancer patients: A cohort studyCornelia Nitipir, Andreea Ioana Parosanu, Mihaela Olaru, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature ReviewIoana-Miruna Stanciu, Cristina Florina Pirlog, Andrei-Wilhelm Anghel, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?Cristina-Florina Pîrlog, Raluca Costache, Andreea Ioana Paroșanu, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell CarcinomaAndreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, et al.
Oncology Letters|January 19, 2018
Update on radionuclide therapy in oncologyCornelia Nitipir, Dana Niculae, Cristina Orlov, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Pageof 3